KCNJ11 and neonatal diabetes mellitus: The majority of heterozygous activating variants in KCNJ11 appear to occur de novo and are responsible for most cases of NDM in non-consanguineous cohorts, with over half of these cases presenting with central nervous system (CNS) involvement (1, 2, 11–14).